Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Feb 25;25(3):14.
doi: 10.1007/s11916-020-00929-w.

Exercise in Treatment of Migraine Including Chronic Migraine

Tae-Jin Song  1 , Min Kyung Chu  2
Affiliations
Review

Exercise in Treatment of Migraine Including Chronic Migraine

Tae-Jin Song et al. Curr Pain Headache Rep. .

Abstract

Purpose of review: With this review, we aimed to investigate the effect of exercise on migraine and explored the possibility of exercise as a treatment option for migraine.

Recent findings: A close association of physical activity and exercise with migraine has been reported in clinical and population-based studies. Recent randomized controlled trials investigating the effect of aerobic exercise as a migraine-preventive treatment have revealed a notable improvement in migraine symptoms. Data on the effect of anaerobic exercise and exercise for flexibility, coordination, and relaxation on migraine are currently insufficient to make any recommendations. Possible pathways for the attenuation of migraine by exercise include the endogenous opioid and cannabinoid systems, brain-derived neurotrophic factor, inflammation, and behavioral/psychological factors. Regarding efficacy, side effects, and health benefits, aerobic exercise is a potentially beneficial strategy in the preventive treatment of migraine. Further studies are needed to delineate an evidence-based exercise program for migraine treatment.

Keywords: Aerobic exercise; Exercise; Headache; Migraine; Physical activity.

PubMed Disclaimer

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
    1. Burch RC, Buse DC, Lipton RB. Migraine: epidemiology, burden, and comorbidity. Neurol Clin. 2019;37(4):631–49. https://doi.org/10.1016/j.ncl.2019.06.001 . - DOI - PubMed
    1. Lipton RB, Munjal S, Buse DC, Alam A, Fanning KM, Reed ML, et al. Unmet acute treatment needs from the 2017 Migraine in America Symptoms and Treatment Study. Headache. 2019;59(8):1310–23. https://doi.org/10.1111/head.13588 . - DOI - PubMed - PMC
    1. Barbanti P, Aurilia C, Egeo G, Fofi L. Migraine prophylaxis: what is new and what we need? Neurol Sci. 2011;32(Suppl 1):S111–5. https://doi.org/10.1007/s10072-011-0526-3 . - DOI - PubMed
    1. Kowacs PA, Piovesan EJ, Tepper SJ. Rejection and acceptance of possible side effects of migraine prophylactic drugs. Headache. 2009;49(7):1022–7. https://doi.org/10.1111/j.1526-4610.2009.01431.x . - DOI - PubMed
    1. Marmura MJ, Silberstein SD, Schwedt TJ. The acute treatment of migraine in adults: the American headache society evidence assessment of migraine pharmacotherapies. Headache. 2015;55(1):3–20. https://doi.org/10.1111/head.12499 . - DOI - PubMed